NO20022645L - Farmasöytisk superdisintegrerende stoff - Google Patents
Farmasöytisk superdisintegrerende stoffInfo
- Publication number
- NO20022645L NO20022645L NO20022645A NO20022645A NO20022645L NO 20022645 L NO20022645 L NO 20022645L NO 20022645 A NO20022645 A NO 20022645A NO 20022645 A NO20022645 A NO 20022645A NO 20022645 L NO20022645 L NO 20022645L
- Authority
- NO
- Norway
- Prior art keywords
- superdisintegrant
- pharmaceutical
- pharmaceutical superdisintegrant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16917499P | 1999-12-06 | 1999-12-06 | |
PCT/US2000/032989 WO2001039746A1 (en) | 1999-12-06 | 2000-12-06 | Pharmaceutical superdisintegrant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022645D0 NO20022645D0 (no) | 2002-06-05 |
NO20022645L true NO20022645L (no) | 2002-08-01 |
Family
ID=22614504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022645A NO20022645L (no) | 1999-12-06 | 2002-06-05 | Farmasöytisk superdisintegrerende stoff |
Country Status (11)
Country | Link |
---|---|
US (2) | US6660303B2 (no) |
EP (1) | EP1244428A1 (no) |
KR (1) | KR20020062323A (no) |
AU (2) | AU771440B2 (no) |
BR (1) | BR0016482A (no) |
CA (1) | CA2393231A1 (no) |
HU (1) | HUP0301333A3 (no) |
IL (1) | IL150053A0 (no) |
MX (1) | MXPA02005562A (no) |
NO (1) | NO20022645L (no) |
WO (1) | WO2001039746A1 (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0204771D0 (en) * | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Fast disintegrating tablets |
WO2004000223A2 (en) * | 2002-06-20 | 2003-12-31 | Orapharma, Inc. | Rapidly disintegrating formulations for treating or preventing mucositis |
SI21221A (sl) * | 2002-06-21 | 2003-12-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Hitro razpadljive tablete |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
US20050244490A1 (en) * | 2003-12-09 | 2005-11-03 | Michael Otto | Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy |
DE602005008721D1 (de) * | 2004-03-10 | 2008-09-18 | Ranbaxy Lab Ltd | Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid |
US20050220865A1 (en) * | 2004-04-02 | 2005-10-06 | Koleng John J | Compressed composition comprising magnesium salt |
EP1737433B1 (en) * | 2004-04-12 | 2007-11-14 | Pfizer Products Incorporated | Taste-masked drugs in rupturing multiparticulates |
EP1852100B1 (en) * | 2005-02-25 | 2018-05-09 | Takeda Pharmaceutical Company Limited | Method for producing coated granules of a benzimidazole compound |
US20070043097A1 (en) * | 2005-07-18 | 2007-02-22 | Horizon Therapeutics, Inc. | Medicaments containing famotidine and ibuprofen and administration of same |
US8067451B2 (en) * | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
US11116728B2 (en) | 2006-11-30 | 2021-09-14 | Bend Research, Inc. | Multiparticulates of spray-coated drug and polymer on a meltable core |
US10357462B2 (en) * | 2006-11-30 | 2019-07-23 | Ben Research, Inc. | Multiparticulates of spray-coated drug and polymer on a meltable core |
WO2008079343A2 (en) * | 2006-12-21 | 2008-07-03 | Mallinckrodt Inc. | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients |
JP5637624B2 (ja) * | 2009-02-12 | 2014-12-10 | 富士化学工業株式会社 | 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物 |
CN105688327A (zh) * | 2009-03-20 | 2016-06-22 | 因卡伯实验室有限责任公司 | 固体形式的药品 |
US20100285164A1 (en) * | 2009-05-11 | 2010-11-11 | Jrs Pharma | Orally Disintegrating Excipient |
US20160008310A1 (en) | 2014-07-11 | 2016-01-14 | Azanta A/S | Misoprostol dispersible tablet |
JP6532529B2 (ja) | 2014-07-11 | 2019-06-19 | アサンタ・デンマーク・アー/エス | ミソプロストール分散性錠剤 |
WO2021174183A1 (en) * | 2020-02-27 | 2021-09-02 | Henkel IP & Holding GmbH | Encapsulated cleansing composition |
CN112618503B (zh) * | 2021-01-20 | 2022-04-15 | 天津市中央药业有限公司 | 头孢地尼分散片 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3141875A (en) | 1961-03-15 | 1964-07-21 | Fmc Corp | Crystallite aggregates disintegrated in acid medium |
GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
US4772473A (en) | 1986-06-16 | 1988-09-20 | Norwich Eaton Pharmaceuticals, Inc. | Nitrofurantoin dosage form |
US4910023A (en) * | 1988-06-09 | 1990-03-20 | Warner-Lambert Company | Drug in combination with flavor masking agent and method for making same |
HU203041B (en) | 1989-03-14 | 1991-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin |
US5468286A (en) * | 1989-10-25 | 1995-11-21 | National Starch And Chemical Investment Holding Corporation | Enzymatically debranched starches as tablet excipients |
IT1241417B (it) | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
CA2041774C (en) | 1990-11-27 | 1994-04-19 | Mircea A. Mateescu | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
US5215757A (en) | 1991-03-22 | 1993-06-01 | The Procter & Gamble Company | Encapsulated materials |
US5272191A (en) | 1991-08-21 | 1993-12-21 | Fmc Corporation | Cold water soluble films and film forming compositions |
ATE137668T1 (de) | 1992-07-24 | 1996-05-15 | Labopharm Inc | Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung |
US5616343A (en) | 1993-03-25 | 1997-04-01 | Labopharm, Inc. | Cross-linked amylose as a binder/disintegrant in tablets |
US5948438A (en) | 1995-01-09 | 1999-09-07 | Edward Mendell Co., Inc. | Pharmaceutical formulations having improved disintegration and/or absorptivity |
US5585115A (en) | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
IL139728A (en) | 1995-01-09 | 2003-06-24 | Penwest Pharmaceuticals Compan | Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient |
US6106865A (en) | 1995-01-09 | 2000-08-22 | Edward Mendell Co., Inc. | Pharmaceutical excipient having improved compressibility |
US5733578A (en) | 1995-11-15 | 1998-03-31 | Edward Mendell Co., Inc. | Directly compressible high load acetaminophen formulations |
TW430561B (en) * | 1995-12-20 | 2001-04-21 | Gea Farmaceutisk Fabrik As | Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet |
CA2217238C (en) | 1997-10-24 | 2005-09-20 | Louis Cartilier | Cross-linked cellulose as a tablet excipient |
-
2000
- 2000-12-06 HU HU0301333A patent/HUP0301333A3/hu unknown
- 2000-12-06 KR KR1020027007259A patent/KR20020062323A/ko not_active IP Right Cessation
- 2000-12-06 US US09/731,238 patent/US6660303B2/en not_active Expired - Fee Related
- 2000-12-06 EP EP00983920A patent/EP1244428A1/en not_active Withdrawn
- 2000-12-06 IL IL15005300A patent/IL150053A0/xx unknown
- 2000-12-06 AU AU20614/01A patent/AU771440B2/en not_active Ceased
- 2000-12-06 CA CA002393231A patent/CA2393231A1/en not_active Abandoned
- 2000-12-06 MX MXPA02005562A patent/MXPA02005562A/es unknown
- 2000-12-06 BR BR0016482-8A patent/BR0016482A/pt not_active Application Discontinuation
- 2000-12-06 WO PCT/US2000/032989 patent/WO2001039746A1/en not_active Application Discontinuation
-
2002
- 2002-06-05 NO NO20022645A patent/NO20022645L/no not_active Application Discontinuation
-
2003
- 2003-10-02 US US10/677,847 patent/US20050100600A1/en not_active Abandoned
-
2004
- 2004-06-10 AU AU2004202515A patent/AU2004202515A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20022645D0 (no) | 2002-06-05 |
WO2001039746A1 (en) | 2001-06-07 |
US6660303B2 (en) | 2003-12-09 |
BR0016482A (pt) | 2002-12-24 |
AU2061401A (en) | 2001-06-12 |
AU2004202515A1 (en) | 2004-07-01 |
HUP0301333A3 (en) | 2005-06-28 |
CA2393231A1 (en) | 2001-06-07 |
KR20020062323A (ko) | 2002-07-25 |
US20020068084A1 (en) | 2002-06-06 |
US20050100600A1 (en) | 2005-05-12 |
IL150053A0 (en) | 2002-12-01 |
AU771440B2 (en) | 2004-03-25 |
MXPA02005562A (es) | 2004-09-10 |
EP1244428A1 (en) | 2002-10-02 |
HUP0301333A2 (hu) | 2004-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022645D0 (no) | Farmasöytisk superdisintegrerende stoff | |
DK1637127T3 (da) | Terapeutisk mikroskum | |
NO20021400D0 (no) | Terapeutiske konazolinderivater | |
ATE392890T1 (de) | Hydrogel-gesteuerte dosierungsform | |
NO20015175L (no) | Farmasöytisk sammensetning | |
DE69930152D1 (de) | Projektor | |
IS2277B (is) | Meðferðarlegar bíarýl afleiður | |
NO20011085D0 (no) | Tablett med umiddelbar frigivningsvirkning | |
NO20022692D0 (no) | Terapeutiske midler | |
DE50001455D1 (de) | Blisterverpackung | |
NO20022606L (no) | Farmasöytiske kombinasjoner | |
NO20005179D0 (no) | Medikament behandling | |
NO20014926L (no) | Farmasöytiske forbindelser | |
FR2802423B1 (fr) | Compositions pharmaceutiques | |
ATE348582T1 (de) | Kondom | |
DE60025760D1 (de) | Anisotrop-leitender film | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
DK1176982T3 (da) | Prucaloprid oral opløsning | |
IS6163A (is) | Lyfjakomplex | |
NO20016301D0 (no) | Terapeutiske midler | |
DE59905747D1 (de) | Blisterpackung | |
ID26141A (id) | Film rentang poliolefin | |
DE50007261D1 (de) | Mehrschichtverbund | |
ATA111699A (de) | Rechenhilfe | |
UA2855S (uk) | Таблетка фармацевтична |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |